This is what life looks like for 1 billion people. Tap "Simulate" again to see clearly.
Pilot · Section iv Jakarta · Indonesia · July 2026

Jakarta. July 2026.

A city of 11.3 million. A ride-share network that already reaches every alleyway. A partner — Gojek — whose drivers need clear vision more than almost any other profession on earth.

§ 01 — Why Jakarta

The three preconditions exist here at the same time.

Market fit

There are three variables that must all align before our model works in a given city: a large population with uncorrected refractive error, widespread smartphone adoption, and a mature third-party logistics network. Jakarta is one of the few megacities on earth where all three variables sit above the threshold we need.

Precondition 01

High prevalence of uncorrected refractive error

Indonesia sits within the band of Southeast Asian countries where vision impairment prevalence reaches 45% and corrective access remains scarce.

Precondition 02

High smartphone penetration

A screening product that runs on the device the user already owns — no additional hardware, no clinical visit.

Precondition 03

Feasible regional logistics

Gojek, GrabExpress, Ninja Van — a delivery infrastructure dense enough to drop a pair of glasses at any address in the metro.

§ 02 — The Partnership

We partner with Gojek to reach the drivers who need it most.

B2B2C

A ride-share driver with uncorrected vision is a public-safety risk to themselves, to their passengers, and to everyone on the road. Gojek absorbs both the moral and the commercial case for correction. Our pilot delivers vision solutions directly to Gojek drivers — subsidized in part by Gojek, screened on their phones, delivered by the same fleet they already belong to.

Selling Structure · Per unit
Total price $10
Gojek subsidy $4
Client pays $6
Pilot parameters
People screened
3,000 – 6,000
Eyewear delivered
300 – 800 pairs
Duration
6 – 9 months
Scale decision gated by predefined validation metrics.
B2B2C. The business pays to protect its workforce. The worker pays what they can afford. Everyone ends up in a position they could not have reached alone.
§ 03 — Local Partners

On the ground in Jakarta.

Partner 01

Glasses supplier

Preliminary collaboration intentions secured. Production capacity matched to pilot volume.

Partner 02

Local 3PL

Established partner organizations providing last-mile delivery across the Jakarta metropolitan area.

Partner 03

Legal & market consultant

Universitas Indonesia Department of Law — with Nuel, a child-rights and education advocate — completing the first phase of market-entry planning.

§ 04 — Roadmap

From Taiwan to Indonesia to the rest of South Asia.

✅ April 2026
Taiwan — Pilot validated
52 students screened at Jinshan Elementary. All four clinical thresholds passed.
🚀 July 2026
Indonesia — Launch & deployment
Jakarta pilot with Gojek. Target: 1,000 users in month one, <30% churn, 2+ local education partnerships.
🌍 Next
India, Nepal, Cambodia — Scale
Regional expansion across South & Southeast Asia where the three preconditions align.
Indonesia launch — key actions
Optimize onboarding
Localize language and payment flows for Indonesian users.
Build customer support
Bilingual support infrastructure for pilot duration.
KPI dashboard
Live monitoring of test accuracy, delivery SLA, and churn.
Education partnerships
Secure 2+ school-level collaborations for youth-focused rollout.
§ 05 — Landscape

The field of existing solutions.

Existing players

Four serious organizations operate in or adjacent to our space: Tzu Chi Foundation, VisionSpring, Sightsavers, and The Eye Care Foundation. Each has strengths — and each has a structural weakness that leaves space for a different approach.

Tzu Chi Foundation VisionSpring Sightsavers The Eye Care Foundation All Good Vision
Type Physical Physical Physical Physical Online
Model Free mobile clinics + volunteer optometrists Affordable glasses via local vendors Advocacy + funding Clinic-based screenings App-based screening + delivery
Immediacy High — same-day at events Low — vendor-dependent Low — funding / program lag Medium — clinic scheduling High — test anytime via phone
End-to-end Partial — not at scale Partial — no screening Low — no direct service Medium — referral required Full — screen → supply → deliver
Affordability Free (donor-funded) Low (~$1–5) Free (grant-funded) Low cost Low cost (~$10)
Scale Regional (Asia) 50+ countries 30+ countries Southeast Asia focus Jakarta pilot
Key weakness Volunteer-dependent, hard to scale No diagnostic capability No direct patient contact Limited logistics Early stage — but replicable
§ 06 — Moat

Why us, why now, why hard to copy.

Proprietary

Not reproducible at $4

The unit economics are only possible because of our supplier terms, standardized lens agreement, and screening stack. Replicating that requires time others do not have.

Reach

Where clinics can't, we already are

Our distribution is native to the cities we enter. No one has to travel; the product arrives.

Immediacy

Test anytime, via the phone in your pocket

Competitors require appointments or volunteer-run events. We require opening an app.